Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk for Second Revision in Patients With Cemented Versus Non-cemented Acetabular Component at Primary THA. A National Cohort Study From DHR

NCT06583382 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT06583382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06583382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk for Second Revision in Patients With Cemented Versus Non-cemented Acetabular Component at Primary THA. A National Cohort Study From DHR
Lead sponsor
Bispebjerg Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
October 1, 2026
Enrollment
60,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

revision hip arthroplasty, total hip arthroplasty (tha)